Literature DB >> 2994785

Inhibition of ionophore-stimulated leukotriene B4 production in human leucocytes by monohydroxy fatty acids.

R D Camp, N J Fincham.   

Abstract

Leukotriene B4 (LTB4) release by calcium ionophore-stimulated human leucocytes was measured by use of selective solvent partition of reaction mixtures and an agarose microdroplet chemokinesis assay, and the inhibitory effects of four monohydroxy fatty acids were determined. 15-Hydroxy-eicosatetraenoic acid (15-HETE) was the most effective inhibitor of LTB4 production with an approximate IC50 value of 6 microM and 99% inhibition at 50 microM, whereas 13-hydroxy-octadecadienoic acid (13-HODD) and 12-HETE were weaker inhibitors with approximate IC50 values of 32 microM and 23 microM, and 59% and 68% inhibition at 50 microM, respectively. We suggest that 13-HODD and 12-HETE, which are present in large amounts in the lesions of the skin disease psoriasis, may act as endogenous modulators of 5-lipoxygenase activity in skin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994785      PMCID: PMC1916659          DOI: 10.1111/j.1476-5381.1985.tb11082.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  Transformation of arachidonic acid in leukocytes. Isolation and structural analysis of a novel dihydroxy derivative.

Authors:  P Borgeat; S Picard; P Vallerand; P Sirois
Journal:  Prostaglandins Med       Date:  1981-06

Review 2.  The pharmacology and pathophysiology of leukotriene B4.

Authors:  M A Bray
Journal:  Br Med Bull       Date:  1983-07       Impact factor: 4.291

3.  Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes.

Authors:  A W Ford-Hutchinson; M A Bray; M V Doig; M E Shipley; M J Smith
Journal:  Nature       Date:  1980-07-17       Impact factor: 49.962

4.  Chemokinetic activity of arachidonic and lipoxygenase products on leuocyctes of different species.

Authors:  R M Palmer; R J Stepney; G A Higgs; K E Eakins
Journal:  Prostaglandins       Date:  1980-08

5.  Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid.

Authors:  J Y Vanderhoek; R W Bryant; J M Bailey
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

6.  The identification of hydroxy fatty acids in psoriatic skin.

Authors:  R D Camp; A I Mallet; P M Woollard; S D Brain; A K Black; M W Greaves
Journal:  Prostaglandins       Date:  1983-09

7.  The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis.

Authors:  S Brain; R Camp; P Dowd; A K Black; M Greaves
Journal:  J Invest Dermatol       Date:  1984-07       Impact factor: 8.551

8.  Production of intraepidermal microabscesses by topical application of leukotriene B4.

Authors:  R Camp; R R Jones; S Brain; P Woollard; M Greaves
Journal:  J Invest Dermatol       Date:  1984-02       Impact factor: 8.551

9.  The effects of some antirheumatic drugs on an in vitro model of human polymorphonuclear leucocyte chemokinesis.

Authors:  M J Smith; J R Walker
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

10.  The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs).

Authors:  E J Goetzl; W C Pickett
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

View more
  11 in total

1.  A neutrophil-derived cytochrome P450-dependent metabolite of arachidonic acid modulates neutrophil behavior.

Authors:  R Kraemer; M M Bednar; M A Hatala; K M Mullane
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

2.  Heterogeneous distribution of lipoxygenase products in psoriatic skin lesions.

Authors:  K Fogh; J Kiil; T Herlin; T Ternowitz; K Kragballe
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

Review 3.  Metabolic interactions between eicosanoids in blood and vascular cells.

Authors:  M Lagarde; N Gualde; M Rigaud
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

4.  Alterations in Epidermal Eicosanoid Metabolism Contribute to Inflammation and Impaired Late Differentiation in FLG-Mutated Atopic Dermatitis.

Authors:  Stefan Blunder; Ralph Rühl; Verena Moosbrugger-Martinz; Christine Krimmel; Anita Geisler; Huiting Zhu; Debra Crumrine; Peter M Elias; Robert Gruber; Matthias Schmuth; Sandrine Dubrac
Journal:  J Invest Dermatol       Date:  2016-10-26       Impact factor: 8.551

5.  Guinea pig epidermis generates putative anti-inflammatory metabolites from fish oil polyunsaturated fatty acids.

Authors:  C Miller; R Y Yamaguchi; V A Ziboh
Journal:  Lipids       Date:  1989-12       Impact factor: 1.880

6.  Linoleic acid and dihomogammalinolenic acid inhibit leukotriene B4 formation and stimulate the formation of their 15-lipoxygenase products by human neutrophils in vitro. Evidence of formation of antiinflammatory compounds.

Authors:  L Iversen; K Fogh; G Bojesen; K Kragballe
Journal:  Agents Actions       Date:  1991-07

7.  The suppression of 5-lipoxygenation of arachidonic acid in human polymorphonuclear leucocytes by the 15-lipoxygenase product (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid: structure-activity relationship and mechanism of action.

Authors:  K Petrich; P Ludwig; H Kühn; T Schewe
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

Review 8.  3D-Organotypic Cultures to Unravel Molecular and Cellular Abnormalities in Atopic Dermatitis and Ichthyosis Vulgaris.

Authors:  Géraldine Leman; Verena Moosbrugger-Martinz; Stefan Blunder; Petra Pavel; Sandrine Dubrac
Journal:  Cells       Date:  2019-05-22       Impact factor: 6.600

9.  Analysis of the gut microbiome to validate a mouse model of pellagra.

Authors:  Natsumi Susai; Tomohiro Kuroita; Koji Kuronuma; Takeshi Yoshioka
Journal:  Biosci Microbiota Food Health       Date:  2022-01-24

Review 10.  Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?

Authors:  Nils Helge Schebb; Hartmut Kühn; Astrid S Kahnt; Katharina M Rund; Valerie B O'Donnell; Nicolas Flamand; Marc Peters-Golden; Per-Johan Jakobsson; Karsten H Weylandt; Nadine Rohwer; Robert C Murphy; Gerd Geisslinger; Garret A FitzGerald; Julien Hanson; Claes Dahlgren; Mohamad Wessam Alnouri; Stefan Offermanns; Dieter Steinhilber
Journal:  Front Pharmacol       Date:  2022-03-02       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.